Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103

2023/01/27 22:00:00
Price
290.08 USD
Difference -0.63% (-1.84)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,425 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)289.00 USD (100)
Ask (Ask size)291.05 USD (1,000)
Open292.36 USD
High295.8962 USD
Low289.94 USD
Close (prev. day)291.92 USD
VWAP292.123444 USD
Volume (pcs)894,286
Trading volume261,343,522.61
Number of trades21,991
Last size116,806

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/01/27 22:00:00
Price
290.08 USD
Difference -0.63% (-1.84)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,425 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)289.00 USD (100)
Ask (Ask size)291.05 USD (1,000)
Open292.36 USD
High295.8962 USD
Low289.94 USD
Close (prev. day)291.92 USD
VWAP292.123444 USD
Volume (pcs)894,286
Trading volume261,343,522.61
Number of trades21,991
Last size116,806

Performance and Risk

6m1Y3Y
Perf (%)+36.24%+32.49%+3.18%
Perf (abs.)+77.16+71.14+8.94
Beta1.050.910.84
Volatility54.9445.4350.13
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)291.63 USD (924,723)
Ø price 30 days | Ø volume 30 days (pcs.)282.88 USD (1,139,723)
Ø price 100 days | Ø volume 100 days (pcs.)269.66 USD (1,514,879)
Ø price 250 days | Ø volume 250 days (pcs.)233.03 USD (1,231,845)
YTD High | date295.90 USD (2023/01/27)
YTD Low | date265.32 USD (2023/01/05)
52 Weeks High | date311.88 USD (2022/11/30)
52 Weeks Low | date187.16 USD (2022/05/09)

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/01/2717:35270.80 EUR0.038
Vienna Stock Exchange2023/01/2717:32270.80 EUR0.013
Tradegate2023/01/2722:26267.15 EUR0.1413
Stuttgart2023/01/3008:00267.80 EUR0.011
SIX Swiss Exchange2022/09/2817:36222.00 CHF0.001
Nasdaq2023/01/2722:00290.08 USD261.3421,991
Munich2023/01/3008:00264.00 EUR0.001
London Stock Exchange2023/01/1912:59283.47 USD3.671
Hanover2023/01/3008:01263.95 EUR0.001
Hamburg2023/01/3008:01263.95 EUR0.001
Frankfurt2023/01/2716:03268.35 EUR0.004
Duesseldorf2023/01/3008:31263.40 EUR0.002
Berlin2023/01/3008:30265.60 EUR0.001
BX Swiss2023/01/1318:00266.237 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
- -
225 Binney Street - 02142 Cambridge
Telefon: 1-617-679-2000
Fax: -
E-mail: info@biogen.com

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Members of Management Board

Stelios PapadopoulosChairman of Board of Directors
Alexander DennerMember of Board of Directors
Eric RowinskyMember of Board of Directors
Maria FreireMember of Board of Directors
Richard MulliganMember of Board of Directors
Stephen SherwinMember of Board of Directors
Caroline DorsaMember of Board of Directors
Jesus MantasMember of Board of Directors
William HawkinsMember of Board of Directors
William JonesMember of Board of Directors
Michel VounatsosChairman of Managing Board
Ginger GregoryMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Michael McDonnellMember of Executive Committee
Rachid IzzarMember of Executive Committee
Susan H. AlexanderMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer